Cargando…
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
Multiple myeloma (MM) is a refractory plasma cell tumor. In myeloma cells, the transcription factor IRF4, the master regulator of plasma cells, is aberrantly upregulated and plays an essential role in oncogenesis. IRF4 forms a positive feedback loop with MYC, leading to additional tumorigenic proper...
Autores principales: | Ikeda, Sho, Tagawa, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486179/ https://www.ncbi.nlm.nih.gov/pubmed/34310776 http://dx.doi.org/10.1111/cas.15087 |
Ejemplares similares
-
Hypoxia‐induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase‐1 in multiple myeloma
por: Abe, Ko, et al.
Publicado: (2023) -
Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2020) -
Hypoxia‐inducible microRNA‐210 regulates the DIMT1‐IRF4 oncogenic axis in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2017) -
The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020) -
Pathogenesis and treatment of multiple myeloma
por: Yang, Peipei, et al.
Publicado: (2022)